Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Herbert Conrad Insider Profile
4 Followers
Herbert Conrad, Director at Celldex, holds 4.69M shares in Matinas BioPharma (Ticker: MTNB), holds 18.50K shares in Celldex (Ticker: CLDX), holds 0.00 shares in Arbutus Biopharma (Ticker: ABUS).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-39.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Herbert Conrad holds in companies
Most Profitable Insider Trade
The most profitable trade made by Herbert Conrad
Herbert Conrad's Trading History
Celldex
Jun 16, 2017
Director
Uninformative Buy
―
$742.03K
Matinas BioPharma
Jul 05, 2022
Director
Uninformative Buy
―
$798.08K
Arbutus Biopharma
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Herbert Conrad's performance on stock
You May Also Like
Herbert Conrad insider profile FAQ
What is the percentage of profitable transactions made by Herbert Conrad?
The percentage of profitable transactions made by Herbert Conrad is 0%.
What is the average return per transaction made by Herbert Conrad?
The average return per transaction made by Herbert Conrad is -39.20%.
What stocks does Herbert Conrad hold?
Herbert Conrad holds: CLDX, MTNB, ABUS stocks.
What was Herbert Conrad’s latest transaction?
Herbert Conrad latest transaction was an Uninformative Buy of ―.
What was Herbert Conrad's most profitable transaction?
Herbert Conrad’s most profitable transaction was an Informative Buy of MTNB stock on May 20, 2019. The return on the trade was -11.70%.
What is Herbert Conrad's role in Celldex?
Herbert Conrad's role in Celldex is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.